Type 1 Diabetes Prevention Moves Toward Reality Type 1 Diabetes Prevention Moves Toward Reality

Teplizumab results extended another year, while other agents are also under study among people with preclinical or new-onset type 1 diabetes.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news